Stock in Tylenol’s parent company rallies after Trump’s unproven claims
Tylenol’s parent company, Kenvue, saw its stock price rebound in premarket trading on Tuesday after U.S. President Donald Trump made unfounded claims about the drug.
Related Articles
Live Updates: Trump Attacks U.N. and Lectures Nations in Address to General Assembly
President Trump’s speech, filled with familiar grievances and false claims, criticized the...
Trump admonishes Europe, questions UN’s ‘purpose’ in speech to world body
Trump returned to the United Nations on Tuesday to boast of his...
West Bank’s Route 60: The ‘road of death’ many Palestinians cannot avoid
In the occupied West Bank, Route 60 links key Palestinian cities with...
‘Going to hell’: Trump blasts Europe, UN in General Assembly speech
Donald #Trump sharply criticised #Europe and the #UN at the General Assembly...
Leave a comment